» Articles » PMID: 35238325

APOE and KLF14 Genetic Variants Are Sex-specific for Low High-density Lipoprotein Cholesterol Identified by a Genome-wide Association Study

Overview
Journal Genet Mol Biol
Specialty Genetics
Date 2022 Mar 3
PMID 35238325
Authors
Affiliations
Soon will be listed here.
Abstract

To demonstrate the loci that relate to high-density lipoprotein cholesterol (HDL-C) levels and genetic sex heterogeneity, we enrolled 41,526 participants aged between 30 and 70 years old from the Taiwan Biobank in a genome-wide association study. We applied the Manhattan plot to display the p-values estimated for the relationships between loci and low HDL-C. A total of 160 variants were significantly associated with low HDL-C. The genotype TT of rs1364422 located in the KLF14 gene has 1.30 (95% CI=1.20 - 1.42) times the risk for low-HDL compared to genotype CC in females (log(-p) =8.98). Moreover, the genes APOC1, APOE, PVRL2, and TOMM40 were associated significantly with low-HDL-C in males only. Excluding the variants with high linkage disequilibrium, we revealed the rs429358 located in APOE as the major genetic variant for lowering HDL-C, in which genotype CT has 1.24 (95% CI= 1.16 - 1.32) times the risk. In addition, we also examine 12 genes related to HDL-C in both sexes, including LPL, ABCA1, APOA5, BUD13, ZPR1, ALDH1A2, LIPC, CETP, HERPUD1, LIPG, ANGPTL8, and DOCK6. In conclusion, low-HDL-C is a genetic and sex-specific phenotype, and we discovered that the APOE and KLF14 are specific to low-HDL-C for men and women, respectively.

Citing Articles

Biochemical Activation and Regulatory Functions of Trans-Regulatory KLF14 and Its Association with Genetic Polymorphisms.

Akash M, Rasheed S, Rehman K, Ibrahim M, Imran M, Assiri M Metabolites. 2023; 13(2).

PMID: 36837818 PMC: 9962810. DOI: 10.3390/metabo13020199.

References
1.
Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray K, Thompson A . Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009; 302(18):1993-2000. PMC: 3284229. DOI: 10.1001/jama.2009.1619. View

2.
Chen X, Li S, Yang Y, Yang X, Liu Y, Hu W . Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. J Thromb Haemost. 2012; 10(8):1508-14. DOI: 10.1111/j.1538-7836.2012.04815.x. View

3.
Weintraub A, Li C, Zamudio A, Sigova A, Hannett N, Day D . YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017; 171(7):1573-1588.e28. PMC: 5785279. DOI: 10.1016/j.cell.2017.11.008. View

4.
Small K, Todorcevic M, Civelek M, El-Sayed Moustafa J, Wang X, Simon M . Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition. Nat Genet. 2018; 50(4):572-580. PMC: 5935235. DOI: 10.1038/s41588-018-0088-x. View

5.
Chung S, Gebre A, Seo J, Shelness G, Parks J . A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion. J Lipid Res. 2010; 51(4):729-42. PMC: 2842152. DOI: 10.1194/jlr.M900083. View